Detected ·

Galvanize Therapeutics

$130MSeries D

Galvanize Therapeutics closed an oversubscribed $130M Series D financing led by HealthQuest Capital to advance its pulsed electric field (PEF) platform for cancer and chronic lung disease.

Website
—
LinkedIn
—
Amount
$130 000 000 USD
Stage
Series D
Event
Funding round
Detected
2026-11-20 00:27:13 UTC
Signal ID
d4869a94-592a-440b-9008-cb312e6d0db8

As the API returns it

{
  "id": "d4869a94-592a-440b-9008-cb312e6d0db8",
  "created_at": "2026-11-20T00:27:13.015894Z",
  "company_name": "Galvanize Therapeutics",
  "company_website_url": null,
  "company_linkedin_url": null,
  "event_type": "funding",
  "funding_amount": 130000000,
  "funding_currency": "USD",
  "funding_stage": "series_d",
  "message": "*Galvanize Therapeutics closed an oversubscribed $130M Series D financing led by HealthQuest Capital to advance its pulsed electric field (PEF) platform for cancer and chronic lung disease.*"
}

Latest rounds